Single-Cell Sequencing in Rheumatic Diseases: New Insights from the Perspective of the Cell Type
Author:
Publisher
Aging and Disease
Subject
Cell Biology,Neurology (clinical),Geriatrics and Gerontology,Pathology and Forensic Medicine
Link
http://www.aginganddisease.org/fileup/2152-5250/PDF/1649556562458-1287564746.pdf
Reference104 articles.
1. Donlin LT, Park SH, Giannopoulou E, Ivovic A, Park-Min KH, Siegel RM, et al. (2019). Insights into rheumatic diseases from next-generation sequencing. Nat Rev Rheumatol, 15:327-339.
2. Kingsmore KM, Grammer AC, Lipsky PE (2020). Drug repurposing to improve treatment of rheumatic autoimmune inflammatory diseases. Nat Rev Rheumatol, 16:32-52.
3. Meednu N, Barnard J, Callahan K, Coca A, Marston B, Thiele R, et al. (2021). Activated peripheral blood B cells in rheumatoid arthritis and relationship to anti-TNF treatment and response: randomized clinical trial for anti-TNF effects on B cells. Arthritis Rheumatol.
4. Allanore Y, Wung P, Soubrane C, Esperet C, Marrache F, Bejuit R, et al. (2020). A randomised, double-blind, placebo-controlled, 24-week, phase II, proof-of-concept study of romilkimab (SAR156597) in early diffuse cutaneous systemic sclerosis. Ann Rheum Dis, 79:1600-1607.
5. Zamanian RT, Badesch D, Chung L, Domsic RT, Medsger T, Pinckney A, et al. (2021). Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis Associated Pulmonary Arterial Hypertension: A Multi-center, Double-blind, Randomized, Placebo-controlled Trial. Am J Respir Crit Care Med, 204:rccm.202009-3481OC.
Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. CTHRC1: An Emerging Hallmark of Pathogenic Fibroblasts in Lung Fibrosis;Cells;2024-05-30
2. Exosomal Proteomics: Unveiling Novel Insights into Lung Cancer;aging and disease;2024
3. The biological significance of cuproptosis-key gene MTF1 in pan-cancer and its inhibitory effects on ROS-mediated cell death of liver hepatocellular carcinoma;Discover Oncology;2023-06-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3